Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Anima will use its mRNA Lightning platform to discover novel mRNA biology modulators against the collaboration targets providing AbbVie exclusive rights to license and further develop and commercialize the programs.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: AbbVie Inc
Deal Size: $582.0 million Upfront Cash: $42.0 million
Deal Type: Collaboration January 10, 2023